Leading the Path for Personalized Medication and Medical Technology: Highlighting the strategies to Overcome Barriers to Adoption, Regulation, and Reimbursement Perspectives
Manon Zoé
Rennes School of Business, France
DOI:https://doi.org/10.5912/jcb1526
Abstract:
The personalized medication enables tailor-made prevention and treatment strategies that can be provided to individuals or patient groups in the form of specifically designed therapies that can work best for them. Search strategies enable low money wastage and save time as there is no need for trial-and-error treatments. However, the adoption of personalized medication and required technology has been slow across the world, including in the European Union. In the scope of the current study, the researcher has focused on the personalized medication landscape in France. The aim of the researcher was to analyze the general information regarding personalized medication within the country, the regulatory and reimbursement processes within the country, and the various barriers and solutions to them. For this purpose, the researcher contacted industry professionals, researchers, and policymakers in order to conduct export interviews to collect the data. Thematic analysis was applied to this data to find out that there are many barriers faced, especially in terms of knowledge and education for personalized medication. However, several benefits and strategies to overcome the regulatory and reimbursement barriers have also been suggested.